Search

Day One Biopharmaceuticals Inc

Fermé

SecteurSoins de santé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Revenu

-21M

Ventes

54M

Marge bénéficiaire

-39.611

Employés

178

EBITDA

-26M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

-3.62% downside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

2.2B

Ouverture précédente

0

Clôture précédente

0

Day One Biopharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 oct. 2026, 23:21 UTC

Macro News
News

Bitcoin declines amid ongoing geopolitical tensions and El Salvador's new 0% tax rate on gains, requiring only a 90-day residency for individuals.

24 oct. 2026, 16:52 UTC

News

Bitcoin is trading lower, continuing a downward trend amid broader market pressures and geopolitical tensions following a fire at a chemical plant in Russia.

24 oct. 2026, 16:01 UTC

News

Ethereum is trading lower, continuing a decline since Friday's close amid mixed U.S. economic signals and broader market pressures affecting cryptocurrencies.

24 oct. 2026, 16:01 UTC

News

Ethereum is trading lower, continuing a decline since Friday's close, reaching a low below its 20-day moving average amid broader market weakness.

24 oct. 2026, 16:01 UTC

News

Bitcoin continues to decline amid ongoing geopolitical tensions and mixed U.S. economic signals, remaining near the low end of its recent range.

24 oct. 2026, 00:06 UTC

News

Allegiant Air exercises six options for Boeing 737-8 aircraft, with a list price exceeding $720 million, set for delivery in 2028.

24 oct. 2026, 00:02 UTC

News

Palo Alto Networks Inc's market capitalization is valued at $284.05 billion, reflecting significant long-term appreciation and a modest increase in after-market trading.

24 oct. 2026, 00:02 UTC

Correlated Moves
News

Salesforce Inc grants 278.07k restricted stock units to 34 employees as part of its Inducement Equity Incentive Plan to integrate new talent.

24 oct. 2026, 00:02 UTC

Social Media
News

ConocoPhillips is trading higher in after-market hours, with its fair value estimated at $149.04 compared to its latest close of $150.80.

24 oct. 2026, 00:02 UTC

Social Media
News

CME Group reported $326.7 billion in Bitcoin derivatives trading volume for Q3, contributing to a modest after-market hours gain.

24 oct. 2026, 00:02 UTC

News

DICK'S Sporting Goods faces renewed scrutiny from class action lawsuits alleging securities fraud related to its Foot Locker acquisition and financial disclosures.

24 oct. 2026, 00:02 UTC

News

Deckers Outdoor Corp's price target lowered to $90 by Telsey Advisory Group, which maintains a Market Perform rating amid recent performance trends.

24 oct. 2026, 00:01 UTC

News

UBS maintains Neutral rating on Rollins Inc and raises price target to $37, with shares modestly higher in after-market trading.

24 oct. 2026, 00:01 UTC

News

Celsius Holdings Inc faces a class action lawsuit from Pomerantz LLP over alleged misleading statements regarding the safety of Alani Nu energy drinks.

24 oct. 2026, 00:01 UTC

News

General Mills Inc has launched EPIC Sticks, a line of meat snacks, as the stock trades modestly higher in after-market hours.

24 oct. 2026, 00:01 UTC

News

Carriage Services Inc plans to release its third-quarter 2026 results on November 4, with a conference call scheduled for November 5 at 8:00 a.m. CT.

23 oct. 2026, 23:56 UTC

News

Sherwin-Williams Co declared a quarterly dividend of $0.80 per share, with shares advancing modestly higher in after-market trading.

23 oct. 2026, 23:56 UTC

News

Hershey Co shares advanced in after-market trading as analysts expect increased earnings and revenue for the September 2026 quarter, driven by brand spending and new product launches.

23 oct. 2026, 23:51 UTC

News

Jefferies maintains Hold rating on RingCentral and raises price target to $75, reflecting ongoing evaluations of the company's market position and growth potential.

23 oct. 2026, 23:51 UTC

News

Wix.com Ltd shares are trading lower in after-market hours following a partnership announcement with K Health to integrate its clinical AI assistant into web technology.

23 oct. 2026, 23:51 UTC

News

Jefferies upgraded MSC Industrial Direct Co to Buy and raised its price target to $135, contributing to the stock's increase in after-market trading.

23 oct. 2026, 23:41 UTC

News

DA Davidson maintained a Neutral rating on Pool Corp and lowered its price target to $200, contributing to the stock's decline in after-market hours.

23 oct. 2026, 23:41 UTC

Social Media
News

CME Group Inc is trading modestly higher in after-market hours, following a report of $326.7 billion in Bitcoin derivatives trading volume for Q3.

23 oct. 2026, 23:21 UTC

News

Pomerantz LLP has filed a class action lawsuit against Papa John's International Inc. over alleged securities fraud and unlawful business practices.

23 oct. 2026, 23:11 UTC

News

Carriage Services Inc. plans to release its third-quarter earnings on November 4, 2026, followed by a conference call on November 5.

23 oct. 2026, 23:11 UTC

News

Telsey Advisory Group maintains Market Perform rating on Deckers Outdoor Corp and lowers price target to $90.

23 oct. 2026, 23:06 UTC

News

Estee Lauder Companies Inc. is trading lower in after-market hours.

23 oct. 2026, 23:06 UTC

News

Dow Inc. reported third-quarter 2026 sales of $11.27 billion and net income of $458 million, with shares modestly lower in after-market trading.

23 oct. 2026, 23:06 UTC

News

Citigroup restricts third-party AI agents from accessing its banking platforms, addressing security concerns shared by major banks like Wells Fargo and JPMorgan Chase.

23 oct. 2026, 23:06 UTC

News

BlackRock Inc trades roughly flat since Friday's close.

Comparaison

Variation de prix

Day One Biopharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

-3.62% baisse

Prévisions sur 12 Mois

Moyen 20.75 USD  -3.62%

Haut 21.5 USD

Bas 17 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

7 ratings

1

Achat

6

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
help-icon Live chat